Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.003 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |